132 related articles for article (PubMed ID: 1675171)
1. Neuropeptides in cerebrospinal fluid in normal-pressure hydrocephalus and dementia.
Wikkelsö C; Ekman R; Westergren I; Johansson B
Eur Neurol; 1991; 31(2):88-93. PubMed ID: 1675171
[TBL] [Abstract][Full Text] [Related]
2. Comparison of DSIP- (delta sleep-inducing peptide) and P-DSIP-like (phosphorylated) immunoreactivity in cerebrospinal fluid of patients with senile dementia of Alzheimer type, multi-infarct syndrome, communicating hydrocephalus and Parkinson's disease.
Ernst A; Cramer H; Strubel D; Kuntzmann F; Schoenenberger GA
J Neurol; 1987 Oct; 235(1):16-21. PubMed ID: 2448424
[TBL] [Abstract][Full Text] [Related]
3. Cerebrospinal fluid neuropeptides in Alzheimer's disease and vascular dementia.
Heilig M; Sjögren M; Blennow K; Ekman R; Wallin A
Biol Psychiatry; 1995 Aug; 38(4):210-6. PubMed ID: 8547442
[TBL] [Abstract][Full Text] [Related]
4. A correlation study of CSF neuropeptides in Alzheimer's and Parkinson's disease.
Jolkkonen J; Hartikainen P; Soikkeli R; Bissette G; Nemeroff C; Riekkinen P
Neuropeptides; 1991 Jun; 19(2):97-102. PubMed ID: 1682848
[TBL] [Abstract][Full Text] [Related]
5. Shunt related changes in somatostatin, neuropeptide Y, and corticotropin releasing factor concentrations in patients with normal pressure hydrocephalus.
Poca MA; Mataró M; Sahuquillo J; Catalán R; Ibañez J; Galard R
J Neurol Neurosurg Psychiatry; 2001 Mar; 70(3):298-304. PubMed ID: 11181849
[TBL] [Abstract][Full Text] [Related]
6. Dementia of different etiologies: vasoactive intestinal polypeptide in CSF.
Wikkelsø C; Fahrenkrug J; Blomstrand C; Johansson BB
Neurology; 1985 Apr; 35(4):592-5. PubMed ID: 3982653
[TBL] [Abstract][Full Text] [Related]
7. Somatostatin cerebrospinal fluid levels in dementia.
Molins A; Catalán R; Sahuquillo J; Castellanos JM; Codina A; Galard R
J Neurol; 1991 Jun; 238(3):168-70. PubMed ID: 1678420
[TBL] [Abstract][Full Text] [Related]
8. Tau protein is a potential biological marker for normal pressure hydrocephalus.
Kudo T; Mima T; Hashimoto R; Nakao K; Morihara T; Tanimukai H; Tsujio I; Koike Y; Tagami S; Mori H; Nakamura Y; Tanaka T; Mori K; Takeda M
Psychiatry Clin Neurosci; 2000 Apr; 54(2):199-202. PubMed ID: 10803815
[TBL] [Abstract][Full Text] [Related]
9. Molecular size distribution of somatostatin-like immunoreactivity in the cerebrospinal fluid of patients with degenerative brain disease.
Rissler K; Cramer H; Schaudt D; Strubel D; Gattaz WF
Neurosci Res; 1986 Feb; 3(3):213-25. PubMed ID: 2871533
[TBL] [Abstract][Full Text] [Related]
10. Processing of neuropeptide Y, galanin, and somatostatin in the cerebrospinal fluid of patients with Alzheimer's disease and frontotemporal dementia.
Nilsson CL; Brinkmalm A; Minthon L; Blennow K; Ekman R
Peptides; 2001 Dec; 22(12):2105-12. PubMed ID: 11786197
[TBL] [Abstract][Full Text] [Related]
11. CSF sulfatide distinguishes between normal pressure hydrocephalus and subcortical arteriosclerotic encephalopathy.
Tullberg M; Månsson JE; Fredman P; Lekman A; Blennow K; Ekman R; Rosengren LE; Tisell M; Wikkelsø C
J Neurol Neurosurg Psychiatry; 2000 Jul; 69(1):74-81. PubMed ID: 10864607
[TBL] [Abstract][Full Text] [Related]
12. [Biochemical investigation of normal pressure hydrocephalus in the assessment of shunt effectiveness].
Kanki T
No To Shinkei; 1988 Feb; 40(2):163-70. PubMed ID: 3370169
[TBL] [Abstract][Full Text] [Related]
13. BDNF serum and CSF concentrations in Alzheimer's disease, normal pressure hydrocephalus and healthy controls.
Laske C; Stransky E; Leyhe T; Eschweiler GW; Maetzler W; Wittorf A; Soekadar S; Richartz E; Koehler N; Bartels M; Buchkremer G; Schott K
J Psychiatr Res; 2007 Aug; 41(5):387-94. PubMed ID: 16554070
[TBL] [Abstract][Full Text] [Related]
14. Neuropeptides in cerebrospinal fluid of patients with Alzheimer's disease and dementia with frontotemporal lobe degeneration.
Edvinsson L; Minthon L; Ekman R; Gustafson L
Dementia; 1993; 4(3-4):167-71. PubMed ID: 8401787
[TBL] [Abstract][Full Text] [Related]
15. CSF somatostatin-like immunoreactivity in dementia.
Beal MF; Growdon JH; Mazurek MF; Martin JB
Neurology; 1986 Feb; 36(2):294-7. PubMed ID: 2868429
[TBL] [Abstract][Full Text] [Related]
16. Clinical study of cerebrospinal fluid neuropeptides in patients with primary trigeminal neuralgia.
Qin ZL; Yang LQ; Li N; Yue JN; Wu BS; Tang YZ; Guo YN; Lai GH; Ni JX
Clin Neurol Neurosurg; 2016 Apr; 143():111-5. PubMed ID: 26918582
[TBL] [Abstract][Full Text] [Related]
17. Ventricular and lumbar cerebrospinal fluid concentrations of Alzheimer's disease biomarkers in patients with normal pressure hydrocephalus and posttraumatic hydrocephalus.
Brandner S; Thaler C; Lelental N; Buchfelder M; Kleindienst A; Maler JM; Kornhuber J; Lewczuk P
J Alzheimers Dis; 2014; 41(4):1057-62. PubMed ID: 24748118
[TBL] [Abstract][Full Text] [Related]
18. Low cerebrospinal fluid concentrations of peptide histidine valine and somatostatin-28 in Alzheimer's disease: altered processing of prepro-vasoactive intestinal peptide and prepro-somatostatin.
Yasuda M; Maeda K; Kakigi T; Minamitani N; Kawaguchi T; Tanaka C
Neuropeptides; 1995 Dec; 29(6):325-30. PubMed ID: 8837959
[TBL] [Abstract][Full Text] [Related]
19. Meningeal derived cerebrospinal fluid proteins in different forms of dementia: is a meningopathy involved in normal pressure hydrocephalus?
Brettschneider J; Riepe MW; Petereit HF; Ludolph AC; Tumani H
J Neurol Neurosurg Psychiatry; 2004 Nov; 75(11):1614-6. PubMed ID: 15489398
[TBL] [Abstract][Full Text] [Related]
20. Do concentrations of neurotransmitters measured in lumbar cerebrospinal fluid reflect the concentrations at brain level?
Gjerris A; Gjerris F; Sørensen PS; Sørensen EB; Christensen NJ; Fahrenkrug J; Rehfeld JF
Acta Neurochir (Wien); 1988; 91(1-2):55-9. PubMed ID: 2899378
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
